A large-scale seroprevalence of Epstein-Barr virus in taiwan

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Chen, Chao Yu ^a,b   Huang, Kuan Ying A ^b   Shen, Jen Hsiang ^a,b   Tsao, Kuo Chien ^a,b   Huang, Yhu Chering ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; VIRUS CAPSID ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DISEASE PREDISPOSITION; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HEALTH SURVEY; HUMAN; INFANT; INFECTION RATE; LIFESTYLE; MALE; PERSONAL HYGIENE; PRESCHOOL CHILD; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RURAL AREA; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE; SOCIAL STATUS; TAIWAN; EPSTEIN-BARR VIRUS INFECTIONS; IMMUNOLOGY; ONSET AGE; UNITED STATES; VIROLOGY;

HUMAN HERPESVIRUS 4; MIRIDAE;

AGE OF ONSET; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; SEROEPIDEMIOLOGIC STUDIES; TAIWAN; UNITED STATES;

EID: 84921776145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115836     Document Type: Article

References (47)

1. Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343: 481-492. doi: 10.1056/ NEJM200008173430707 PMID: 10944566
2. Balfour HH Jr, Odumade OA, Schmeling DO, Mullan BD, Ed JA, et al. (2013) Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis 207: 80-88. doi: 10.1093/infdis/jis646 PMID: 23100562
3. Tsai MH, Hsu CY, Yen MH, Yan DC, Chiu CH, et al. (2005) Epstein-Barr virus-associated infectious mononucleosis and risk factor analysis for complications in hospitalized children. J Microbiol Immunol Infect 38: 255-261. PMID: 16118672
4. Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, et al. (2001) Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 98: 280-286. doi: 10.1182/blood.V98.2.280 PMID: 11435294
5. Chen CJ, Huang YC, Jaing TH, Hung IJ, Yang CP, et al. (2004) Hemophagocytic syndrome: a review of 18 pediatric cases. J Microbiol Immunol Infect 37: 157-163. PMID: 15221035
6. Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350: 1328-1337. doi: 10.1056/NEJMra032015 PMID: 15044644
7. Balfour HH Jr, Sifakis F, Sliman JA, Knight JA, Schmeling DO, et al. (2013) Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. J Infect Dis 208: 1286-1293. doi: 10.1093/infdis/jit321 PMID: 23868878
8. Svahn A, Berggren J, Parke A, Storsaeter J, Thorstensson R, et al. (2006) Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years. J Clin Virol 37: 118-123. doi: 10.1016/j.jcv.2006.07.012 PMID: 16971177
9. Crowcroft NS, Vyse A, Brown DW, Strachan DP (1998) Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland. J Epidemiol Community Health 52: 101-104. doi: 10.1136/jech.52.2.101 PMID: 9578856
10. Sidorchuk A, Lagarde F, Pershagen G, Wickman M, Linde A (2003) Epstein-Barr virus infection is not associated with development of allergy in children. Pediatr Infect Dis J 22: 642-647. doi: 10.1097/01. inf.0000076510.41038.a8 PMID: 12867841
11. Tsai WS, Chang MH, Chen JY, Lee CY, Liu YG (1989) Seroepidemiological study of Epstein-Barr virus infection in children in Taipei. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 30: 81-86. PMID: 2561579
12. Takeuchi K, Tanaka-Taya K, Kazuyama Y, Ito YM, Hashimoto S, et al. (2006) Prevalence of Epstein-Barr virus in Japan: trends and future prediction. Pathol Int 56: 112-116. doi: 10.1111/j.1440-1827. 2006.01936.x PMID: 16497243
13. Wang PS, Evans AS (1986) Prevalence of antibodies to Epstein-Barr virus and cytomegalovirus in sera from a group of children in the People's Republic of China. J Infect Dis 153: 150-152. doi: 10.1093/ infdis/153.1.150 PMID: 3001190
14. Pancharoen C, Mekmullica J, Chinratanapisit S, Bhattarakosol P, Thisyakorn U (2001) Seroprevalence of Epstein-Barr virus antibody among children in various age groups in Bangkok, Thailand. Asian Pac J Allergy Immunol 19: 135-137. PMID: 11699720
15. Kangro HO, Osman HK, Lau YL, Heath RB, Yeung CY, et al. (1994) Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J Med Virol 43: 91-96. doi: 10.1002/jmv. 1890430117 PMID: 8083655
16. Haque T, Iliadou P, Hossain A, Crawford DH (1996) Seroepidemiological study of Epstein-Barr virus infection in Bangladesh. J Med Virol 48: 17-21. doi: 10.1002/(SICI)1096-9071(199601)48:1<17::AIDJMV3> 3.0.CO;2-O PMID: 8825705
17. Xiong G, Zhang B, Huang MY, Zhou H, Chen LZ, et al. (2014) Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence. PLoS One 9: e99857. doi: 10.1371/ journal.pone.0099857 PMID: 24914816
18. Dowd JB, Palermo T, Brite J, McDade TW, Aiello A (2013) Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS One 8: e64921. doi: 10.1371/journal.pone.0064921 PMID: 23717674
19. Higgins CD, Swerdlow AJ, Macsween KF, Harrison N, Williams H, et al. (2007) A study of risk factors for acquisition of Epstein-Barr virus and its subtypes. J Infect Dis 195: 474-482. doi: 10.1086/510854 PMID: 17230406
20. Levine H, Balicer RD, Rozhavski V, Halperin T, Shreberk M, et al. (2012) Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults. Ann Epidemiol 22: 783-788. doi: 10.1016/j.annepidem.2012.06.099 PMID: 22831994
21. Sokal EM, Hoppenbrouwers K, Vandermeulen C, Moutschen M, Léonard P, et al. (2007) Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. J Infect Dis 196: 1749-1753. doi: 10.1086/523813 PMID: 18190254
22. Epstein MA, Morgan AJ, Finerty S, Randle BJ, Kirkwood JK (1985) Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature 318: 287-289. doi: 10.1038/318287a0 PMID: 2999604
23. Chen CJ, Lee PI, Hsieh YC, Chen PY, Ho YH, et al. (2012) Waning population immunity to measles in Taiwan. Vaccine 30: 6721-6727. doi: 10.1016/j.vaccine.2012.05.019 PMID: 22634294
24. Chen CJ, Lee PI, Chang SC, Huang YC, Chiu CH, et al. (2011) Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan. PLoS One 6: e24440. doi: 10.1371/journal.pone.0024440 PMID: 21909433
25. Gerber P, Lucas S, Nonoyama M, Perlin E, Goldstein LI (1972) Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet 2: 988-989. doi: 10.1016/S0140-6736(72)92402-6 PMID: 4116980
26. Miller G, Niederman JC, Andrews LL (1973) Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N Engl J Med 288: 229-232. doi: 10.1056/NEJM197302012880503 PMID: 4345064
27. Lemon SM, Hutt LM, Shaw JE, Li JL, Pagano JS (1977) Replication of EBV in epithelial cells during infectious mononucleosis. Nature 268: 268-270. doi: 10.1038/268268a0 PMID: 196210
28. Heath CW Jr, Brodsky AL, Potolsky AI (1972) Infectious mononucleosis in a general population. Am J Epidemiol 95: 46-52. PMID: 5007364
29. Macsween KF, Higgins CD, McAulay KA, Williams H, Harrison N, et al. (2010) Infectious mononucleosis in university students in the United kingdom: evaluation of the clinical features and consequences of the disease. Clin Infect Dis 50: 699-706. doi: 10.1086/650456 PMID: 20121570
30. Cheng CC, Chang LY, Shao PL, Lee PI, Chen JM, et al. (2007) Clinical manifestations and quantitative analysis of virus load in Taiwanese children with Epstein-Barr virus-associated infectious mononucleosis. J Microbiol Immunol Infect 40: 216-221. PMID: 17639161
31. Jenson H, McIntosh K, Pitt J, Husak S, Tan M, et al. (1999) Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1. J Infect Dis 179: 1395-1404. doi: 10.1086/314764 PMID: 10228060
32. Odumade OA, Hogquist KA, Balfour HH Jr (2011) Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev 24: 193-209. doi: 10.1128/CMR.00044-10 PMID: 21233512
33. Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, et al. (2008) Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis 8: 111. doi: 10.1186/1471-2334-8-111 PMID: 18706107
34. Sumaya CV, Henle W, Henle G, Smith MH, LeBlanc D (1975) Seroepidemiologic study of Epstein-Barr virus infections in a rural community. J Infect Dis 131: 403-408. doi: 10.1093/infdis/131.4.403 PMID: 163869
35. Biggar RJ, Gardiner C, Lennette ET, Collins WE, Nkrumah FK, et al. (1981) Malaria, sex, and place of residence as factors in antibody response to Epstein-Barr virus in Ghana, West Africa. Lancet 2: 115-118. doi: 10.1016/S0140-6736(81)90299-3 PMID: 6113482
36. Wagner HJ, Hornef M, Teichert HM, Kirchner H (1994) Sex difference in the serostatus of adults to the Epstein-Barr virus. Immunobiology 190: 424-429. doi: 10.1016/S0171-2985(11)80613-3 PMID: 7982725
37. Beagley KW, Gockel CM (2003) Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 38: 13-22. doi: 10.1016/S0928-8244(03)00202-5 PMID: 12900050
38. Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, et al. (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286: 3083-3088. doi: 10.1001/jama. 286.24.3083 PMID: 11754673
39. Rezza G, Danaya RT, Wagner TM, Sarmati L, Owen IL, et al. (2001) Human herpesvirus-8 and other viral infections, Papua New Guinea. Emerg Infect Dis 7: 893-895. doi: 10.3201/eid0705.010522 PMID: 11747707
40. United Nations (2007) World Urbanization Prospects: The 2007 Revision Highlights. New York: United Nations, Department of Economics and Social Affairs, Population Division.
41. Ho SPS (1982) Economic development and rural industry in South Korea and Taiwan. World Development 10: 973-990. doi: 10.1016/0305-750X(82)90036-5
42. Crawford DH, Macsween KF, Higgins CD, Thomas R, McAulay K, et al. (2006) A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin Infect Dis 43: 276-282. doi: 10.1086/505400 PMID: 16804839
43. Hess RD (2004) Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol 42: 3381-3387. doi: 10.1128/JCM.42.8.3381-3387.2004 PMID: 15297472
44. Jenson HB (2011) Epstein-Barr virus. Pediatr Rev 32: 375-383. doi: 10.1542/pir.32-9-375 PMID: 21885661
45. Venkitaraman AR, Lenoir GM, John TJ (1985) The seroepidemiology of infection due to Epstein-Barr virus in southern India. J Med Virol 15: 11-16. doi: 10.1002/jmv.1890150103 PMID: 2981976
46. Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, et al. (1969) Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst 43: 1147-1157. PMID: 5353242
47. Gärtner BC, Hess RD, Bandt D, Kruse A, Rethwilm A, et al. (2003) Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method. Clin Diagn Lab Immunol 10: 78-82. PMID: 12522043